483
Louisville Reproductive CenterFDA 483 - Louisville Reproductive Center - April 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Louisville Reproductive Center, a human tissue establishment, was cited for three observations during an FDA inspection. The primary issues involved failures in testing semen donors for relevant communicable disease agents, including HIV, HBV, HCV, West Nile Virus, HBc, and HTLV 1 and 2. Additionally, the firm failed to quarantine Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) until donor eligibility determinations were completed.
- Person
Open in Dashboard
ID · e470cebd-8996-4a43-9324-227bd02f7bf4